Table 4.
Medication Usage
| CDTM, % | Traditional, % | p | |
|---|---|---|---|
| ACE-I or ARB* | 73 | 61 | 0.13 |
| ACE-I | 62 | 57 | 0.37 |
| ARB | 14 | 4 | 0.03 |
| Aldosterone antagonist | 1 | 0 | - |
| Alpha agonist | 11 | 5 | 0.22 |
| Amiloride | 2 | 0 | - |
| Beta blocker | 13 | 23 | 0.11 |
| Calcium channel blocker (dihydropyridine) | 28 | 33 | 0.52 |
| Calcium channel blocker (non-dihydropyridine) | 1 | 1 | 0.94 |
| Thiazide-like antihypertensive | 27 | 16 | 0.08 |
ACE-I, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CDTM, collaborative drug therapy management
* Some patients received both an ACE-I and ARB at different times in their therapy (no patients received an ACE-I and ARB concomitantly).